Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.19.3
Accrued Expenses
9 Months Ended
Sep. 30, 2019
Payables And Accruals [Abstract]  
Accrued Expenses

7. Accrued Expenses

Accrued expenses consisted of the following as of September 30, 2019 and December 31, 2018 (in thousands):

 

 

 

September 30, 2019

 

 

December 31, 2018

 

External research and preclinical development

 

$

7,271

 

 

$

10,119

 

Employee compensation and benefits

 

 

3,323

 

 

 

2,985

 

Professional fees

 

 

549

 

 

 

618

 

Facilities and other

 

 

61

 

 

 

171

 

 

 

$

11,204

 

 

$

13,893